4//SEC Filing
Blaustein Marc 4
Accession 0000899243-22-034125
CIK 0001733257other
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 4:31 PM ET
Size
5.9 KB
Accession
0000899243-22-034125
Insider Transaction Report
Form 4
Blaustein Marc
Chief Operating Officer
Transactions
- Sale
Common Stock
2022-10-21$1.39/sh−3,636$5,054→ 32,614 total
Footnotes (2)
- [F1]Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]Represents the weighted average price of shares sold by the broker on behalf of certain executive officers and employees of the company on October 21, 2022. The broker sold, in the aggregate on behalf of such employees, 21,137 shares in transactions ranging from $1.31 to $1.44 with a weighted average price of $1.39. The proceeds of all such sales were allocated to applicable employees on a pro rata basis based on the number of shares sold by such person. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Finch Therapeutics Group, Inc.
CIK 0001733257
Entity typeother
Related Parties
1- filerCIK 0001880032
Filing Metadata
- Form type
- 4
- Filed
- Oct 24, 8:00 PM ET
- Accepted
- Oct 25, 4:31 PM ET
- Size
- 5.9 KB